This information was published on 2025-04-02T12:39:57 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2491996 (IR 1813039) |
| (220) |
29 Apr 2024
|
| (300) |
US, 31 Oct 2023, 98248592
|
| (511) (510) |
Class 1
Proteins for use in manufacture; synthetic proteins and synthetic peptides, in raw material form, for scientific and medical research. Class 5 Synthetic proteins and synthetic peptides for medical diagnostic purposes; synthetic proteins and synthetic peptides for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use. Class 40 Custom manufacturing of genetically engineered proteins and peptides; custom manufacturing of engineered proteins and peptides; custom manufacturing and custom synthesis of engineered proteins and peptides for scientific, engineering, research, and medical use. Class 42 Pharmaceutical, medical, scientific, and biopharmaceutical research and development; research and development of new products in the fields of proteins and peptides; scientific and medical research in the field of proteins and peptides; scientific and engineering research services relating to synthetic biology, genetic engineering, biotechnology and biological engineering; computer-aided design of genetically engineered proteins and peptides; computer-aided design of engineered proteins and peptides. |
| (540) | SYNTEIN |
| (550) | Word |
| (730) |
Abiologics, Inc.
|
Find out more about publications on the About page.